Aisling Capital LLC Holdings Report (13F Filings)

CIK: 0001571076

Concentrated strategyQuality / disciplined sizing

Total reported value

$45.3M

Reporting period: 2019-09-30 · Number of holdings: 5

Aisling Capital LLC disclosed 5 holdings in its latest 13F filing for the period ending 2019-09-30, with total reported value of $45.3M and a quarterly turnover rate of 36.7%.

Browse other institutions with under $100M AUM Browse other institutions starting with "A"

Personality snowflake

Concentration: 100
Portfolio Stability: 36.67
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 10
Sizing Uniformity: 87.32

Sector classification currently covers about 35% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.

Recent moves

Add ADMA
0.0%　$2.1M
Trim AIMT
-37.7%　-$15.5M
Trim TRXCEUR
0.0%　-$1.7M
Add 171757107
-12.7%　$63.0K
New buy VRAYQ

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	AIMT	Aimmune Therapeutics INC	Stock-Other	57.34%	-11.33%	-37.69%
2	ADMA	Adma Biologics INC	Stock-Healthcare	35.46%	+12.32%	—
3	✓	Cidara Therapeutics INC Com New	Stock-Other	3.93%	+1.09%	-12.69%
4	TRXCEUR	Transenterix INC	Stock-Other	3.27%	-2.08%	—
5	VRAYQ	Viewray INC	Stock-Other	—	—	NEW

Portfolio Performance

Not enough priced holdings yet to compute performance

Reported value over time

Sector allocation

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2019-09-30	5	$45.3M	37	1AIMT 2ADMA3171757 Top holdings2019-09-30 1.AIMT 2.ADMA 3.171757 4.TRXCEUR
2019-06-30	4	$60.3M	11	1AIMT 2ADMA 3TRXCEUR Top holdings2019-06-30 1.AIMT 2.ADMA 3.TRXCEUR 4.171757
2019-03-31	4	$66.5M	100	1AIMT 2ADMA 3TRXCEUR Top holdings2019-03-31 1.AIMT 2.ADMA 3.TRXCEUR 4.171757
2018-12-31	9	$353.1M	27	15488622AIMT 3ADMA Top holdings2018-12-31 1.548862 2.AIMT 3.ADMA 4.TRXCEUR 5.171757 6.VRAYQ 7.CMRXEUR 8.GTAQ 9.PTX 4.25 04-01-21
2018-09-30	9	$462.7M	51	15488622AIMT 3ADMA Top holdings2018-09-30 1.548862 2.AIMT 3.ADMA 4.VRAYQ 5.TRXCEUR 6.171757 7.CMRXEUR 8.PTX 4.25 04-01-21 9.GTAQ
2018-06-30	9	$761.9M	35	15488622AIMT 3VRAYQ Top holdings2018-06-30 1.548862 2.AIMT 3.VRAYQ 4.TRXCEUR 5.ADMA 6.171757 7.CMRXEUR 8.PTX 4.25 04-01-21 9.GTAQ
2018-03-31	10	$561.1M	32	15488622AIMT 3VRAYQ Top holdings2018-03-31 1.548862 2.AIMT 3.VRAYQ 4.TRXCEUR 5.ADMA 6.171757 7.AGRXUSD 8.CMRXEUR 9.PTX 4.25 04-01-21 10.GTAQ
2017-12-31	12	$506.2M	34	15488622AIMT 3VRAYQ Top holdings2017-12-31 1.548862 2.AIMT 3.VRAYQ 4.TRXCEUR 5.29363K 6.ADMA 7.171757 8.SYRSEUR 9.AGRXUSD 10.CMRXEUR
2017-09-30	14	$608.7M	24	15488622AIMT 3VRAYQ Top holdings2017-09-30 1.548862 2.AIMT 3.VRAYQ 4.ESPR 5.TRXCEUR 6.ADMA 7.29363K 8.171757 9.AGRXUSD 10.SYRSEUR
2017-06-30	16	$583.9M	55	15488622AIMT 3VRAYQ Top holdings2017-06-30 1.548862 2.AIMT 3.VRAYQ 4.ESPR 5.92529L 6.ADMA 7.PRTKEUR 8.SYRSEUR 9.171757 10.TRXCEUR
2017-03-31	17	$549.3M	29	1548862298933Q3AIMT Top holdings2017-03-31 1.548862 2.98933Q 3.AIMT 4.VRAYQ 5.92529L 6.ESPR 7.ADMA 8.89853L 9.TRXCEUR 10.PRTKEUR
2016-12-31	18	$430.1M	36	1548862298933Q3AIMT Top holdings2016-12-31 1.548862 2.98933Q 3.AIMT 4.92529L 5.VRAYQ 6.ESPR 7.ADMA 8.89853L 9.TRXCEUR 10.171757
2016-09-30	20	$485.4M	28	1548862298933Q3CTH Top holdings2016-09-30 1.548862 2.98933Q 3.CTH 4.AIMT 5.VRAYQ 6.92529L 7.15130J 8.ADMA 9.ESPR 10.89853L
2016-06-30	22	$423.5M	30	1548862298933Q3AIMT Top holdings2016-06-30 1.548862 2.98933Q 3.AIMT 4.VRAYQ 5.92529L 6.89853L 7.ADMA 8.15130J 9.AGRXUSD 10.CTH
2016-03-31	22	$499.4M	33	1548862298933Q3AIMT Top holdings2016-03-31 1.548862 2.98933Q 3.AIMT 4.TRXCEUR 5.VRAYQ 6.ADMA 7.89853L 8.ESPR 9.15130J 10.DERMEUR
2015-12-31	22	$579.8M	27	1548862215130J398933Q Top holdings2015-12-31 1.548862 2.15130J 3.98933Q 4.AIMT 5.ESPR 6.89853L 7.AGRXUSD 8.ADMA 9.DERMEUR 10.92529L
2015-09-30	22	$568.8M	54	198933Q2AIMT315130J Top holdings2015-09-30 1.98933Q 2.AIMT 3.15130J 4.548862 5.ESPR 6.ADMA 7.CMRXEUR 8.92529L 9.DERMEUR 10.89853L
2015-06-30	18	$671.6M	25	1ESPR298933Q315130J Top holdings2015-06-30 1.ESPR 2.98933Q 3.15130J 4.548862 5.CMRXEUR 6.89853L 7.92529L 8.ADMA 9.SRNE 10.AGRXUSD
2015-03-31	19	$764.2M	34	1ESPR215130J398933Q Top holdings2015-03-31 1.ESPR 2.15130J 3.98933Q 4.548862 5.92529L 6.89853L 7.CMRXEUR 8.ADMA 9.CTLTEUR 10.AGRXUSD
2014-12-31	19	$659.6M	51	1ESPR215130J398933Q Top holdings2014-12-31 1.ESPR 2.15130J 3.98933Q 4.CMRXEUR 5.CTLTEUR 6.89853L 7.92529L 8.548862 9.ADMA 10.PRTKEUR
2014-09-30	18	$515.7M	59	198933Q2ESPR389853L Top holdings2014-09-30 1.98933Q 2.ESPR 3.89853L 4.548862 5.CTLTEUR 6.CMRXEUR 7.92529L 8.TRXCEUR 9.15130J 10.26658A
2014-06-30	16	$346.0M	100	192529L2TRXCEUR398933Q Top holdings2014-06-30 1.92529L 2.TRXCEUR 3.98933Q 4.15130J 5.26658A 6.CMRXEUR 7.ESPR 8.AGRXUSD 9.71426V 10.SRNE
2014-03-31	5	$143.9M	41	174876Y226658A3CMRXEUR Top holdings2014-03-31 1.74876Y 2.26658A 3.CMRXEUR 4.MEIPUSD 5.SRNE
2013-12-31	6	$163.6M	0	174876Y226658A3CMRXEUR Top holdings2013-12-31 1.74876Y 2.26658A 3.CMRXEUR 4.ICPTUSD 5.57232I 6.SRNE

Holding changes this quarter

Aisling Capital LLC's most significant position changes for 2019-09-30: New buy: Viewray INC (VRAYQ); Trim: Aimmune Therapeutics INC (AIMT) — shares -37.69%; Trim: Cidara Therapeutics INC Com New — shares -12.69%.

Position changes disclosed by Aisling Capital LLC for the quarter ending 2019-09-30, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	ADMA	Adma Biologics INC	+12.3%	—	Unchanged
2	✓	Cidara Therapeutics INC Com New	+1.1%	-12.69%	Trim
3	TRXCEUR	Transenterix INC	-2.1%	—	Unchanged
4	AIMT	Aimmune Therapeutics INC	-11.3%	-37.69%	Trim
5	VRAYQ	Viewray INC	—	NEW	New buy

Filing History

Period	Filed	Type	EDGAR
2019-09-30	2019-11-13	13F-HR	View on EDGAR
2019-06-30	2019-08-08	13F-HR	View on EDGAR
2019-03-31	2019-05-07	13F-HR	View on EDGAR
2018-12-31	2019-02-11	13F-HR	View on EDGAR
2018-09-30	2018-11-05	13F-HR	View on EDGAR
2018-06-30	2018-08-13	13F-HR	View on EDGAR
2018-03-31	2018-05-14	13F-HR	View on EDGAR
2017-12-31	2018-02-07	13F-HR	View on EDGAR
2017-09-30	2017-11-09	13F-HR	View on EDGAR
2017-06-30	2017-08-14	13F-HR	View on EDGAR
2017-03-31	2017-05-10	13F-HR	View on EDGAR
2016-12-31	2017-02-13	13F-HR	View on EDGAR
2016-09-30	2016-11-10	13F-HR	View on EDGAR
2016-06-30	2016-08-12	13F-HR	View on EDGAR
2016-03-31	2016-05-13	13F-HR	View on EDGAR
2015-12-31	2016-02-10	13F-HR	View on EDGAR
2015-09-30	2015-11-13	13F-HR	View on EDGAR
2015-06-30	2015-08-14	13F-HR	View on EDGAR
2015-03-31	2015-05-11	13F-HR	View on EDGAR
2014-12-31	2015-02-13	13F-HR	View on EDGAR
2014-09-30	2014-11-17	Amendment	View on EDGAR
2014-09-30	2014-11-13	13F-HR	View on EDGAR
2014-06-30	2014-09-12	Amendment	View on EDGAR
2014-06-30	2014-08-08	13F-HR	View on EDGAR
2014-03-31	2014-05-13	13F-HR	View on EDGAR
2013-12-31	2014-02-13	13F-HR	View on EDGAR

FAQ

What is Aisling Capital LLC and what type of investor is it?

Aisling Capital LLC is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2019-09-30), the firm manages a tracked equity portfolio valued at approximately $45.3M, spread across 5 disclosed positions.

What are Aisling Capital LLC's largest equity positions?

Based on the latest 13F filing, Aisling Capital LLC's top holdings by market value are: 1. Aimmune Therapeutics INC (AIMT) — $26.0M (57.3%) 2. Adma Biologics INC (ADMA) — $16.1M (35.5%) 3. Cidara Therapeutics INC Com New — $1.8M (3.9%) 4. Transenterix INC (TRXCEUR) — $1.5M (3.3%) 5. Viewray INC (VRAYQ) — $0.0

What changes did Aisling Capital LLC make in its most recent portfolio filing?

In the latest reported quarter, Aisling Capital LLC made 3 notable position adjustments: 1 new positions were initiated, 0 existing holdings were added to, 2 positions were partially reduced, and 0 were completely exited. The largest of these moves: New buy: Viewray INC (VRAYQ); Trim: Aimmune Therapeutics INC (AIMT) — shares -37.69%; Trim: Cidara Therapeutics INC Com New — shares -12.69%

What sectors does Aisling Capital LLC focus on?

Aisling Capital LLC is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%

Peer Institutions

Institutions with a similar AUM

Meritech Capital Associates VI L.L.C.

CIK 0001741044

Total reported value

$45.3M

2 stks

2023-09-30

Stale — no recent filing

Concentration100.0

Portfolio Stability0.0

Sector conviction100.0

AUM within 0.0% of this institution

View detail

Sonic GP LLC

CIK 0001964290

Total reported value

$45.4M

15 stks

2024-12-31

Stale — no recent filing

Concentration64.3

Portfolio Stability0.0

Sector conviction100.0

AUM within 0.2% of this institution

View detail

PhaseCapital LP

CIK 0001619495

Total reported value

$45.2M

27 stks

2018-09-30

Stale — no recent filing

Concentration69.0

Portfolio Stability44.5

Sector conviction0.0

AUM within 0.2% of this institution

View detail

Similar Holdings Style

Institutions with overlapping top holdings

Stonepine Capital Management, LLC

CIK 0001440771

Total reported value

$249.7M

83 stks

2026-03-31

Concentration74.4

Portfolio Stability100.0

Sector conviction100.0

1 of the top 5 holdings overlap, including Adma Biologics INC

View detail

Biomark Capital Management Co. LLC

CIK 0001667082

Total reported value

$8.9M

2 stks

2018-09-30

Stale — no recent filing

Concentration100.0

Portfolio Stability31.8

Sector conviction0.0

1 of the top 5 holdings overlap, including Adma Biologics INC

View detail

B Group, Inc.

CIK 0002043476

Total reported value

$134.9M

20 stks

2026-03-31

Concentration40.1

Portfolio Stability43.3

Sector conviction100.0

1 of the top 5 holdings overlap, including Adma Biologics INC

View detail

Aisling Capital LLC Holdings Report (13F Filings)

CIK: 0001571076

Concentrated strategyQuality / disciplined sizing

Total reported value

$45.3M

Reporting period: 2019-09-30 · Number of holdings: 5

Aisling Capital LLC disclosed 5 holdings in its latest 13F filing for the period ending 2019-09-30, with total reported value of $45.3M and a quarterly turnover rate of 36.7%.

Browse other institutions with under $100M AUM Browse other institutions starting with "A"

Personality snowflake

Concentration: 100
Portfolio Stability: 36.67
Momentum/Contrarian: 50
Sector conviction: 0
Diversification: 10
Sizing Uniformity: 87.32

Recent moves

Add ADMA
0.0%　$2.1M
Trim AIMT
-37.7%　-$15.5M
Trim TRXCEUR
0.0%　-$1.7M
Add 171757107
-12.7%　$63.0K
New buy VRAYQ

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	AIMT	Aimmune Therapeutics INC	Stock-Other	57.34%	-11.33%	-37.69%
2	ADMA	Adma Biologics INC	Stock-Healthcare	35.46%	+12.32%	—
3	✓	Cidara Therapeutics INC Com New	Stock-Other	3.93%	+1.09%	-12.69%
4	TRXCEUR	Transenterix INC	Stock-Other	3.27%	-2.08%	—
5	VRAYQ	Viewray INC	Stock-Other	—	—	NEW

Portfolio Performance

Not enough priced holdings yet to compute performance

Reported value over time

Sector allocation

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2019-09-30	5	$45.3M	37	1AIMT 2ADMA3171757 Top holdings2019-09-30 1.AIMT 2.ADMA 3.171757 4.TRXCEUR
2019-06-30	4	$60.3M	11	1AIMT 2ADMA 3TRXCEUR Top holdings2019-06-30 1.AIMT 2.ADMA 3.TRXCEUR 4.171757
2019-03-31	4	$66.5M	100	1AIMT 2ADMA 3TRXCEUR Top holdings2019-03-31 1.AIMT 2.ADMA 3.TRXCEUR 4.171757
2018-12-31	9	$353.1M	27	15488622AIMT 3ADMA Top holdings2018-12-31 1.548862 2.AIMT 3.ADMA 4.TRXCEUR 5.171757 6.VRAYQ 7.CMRXEUR 8.GTAQ 9.PTX 4.25 04-01-21
2018-09-30	9	$462.7M	51	15488622AIMT 3ADMA Top holdings2018-09-30 1.548862 2.AIMT 3.ADMA 4.VRAYQ 5.TRXCEUR 6.171757 7.CMRXEUR 8.PTX 4.25 04-01-21 9.GTAQ
2018-06-30	9	$761.9M	35	15488622AIMT 3VRAYQ Top holdings2018-06-30 1.548862 2.AIMT 3.VRAYQ 4.TRXCEUR 5.ADMA 6.171757 7.CMRXEUR 8.PTX 4.25 04-01-21 9.GTAQ
2018-03-31	10	$561.1M	32	15488622AIMT 3VRAYQ Top holdings2018-03-31 1.548862 2.AIMT 3.VRAYQ 4.TRXCEUR 5.ADMA 6.171757 7.AGRXUSD 8.CMRXEUR 9.PTX 4.25 04-01-21 10.GTAQ
2017-12-31	12	$506.2M	34	15488622AIMT 3VRAYQ Top holdings2017-12-31 1.548862 2.AIMT 3.VRAYQ 4.TRXCEUR 5.29363K 6.ADMA 7.171757 8.SYRSEUR 9.AGRXUSD 10.CMRXEUR
2017-09-30	14	$608.7M	24	15488622AIMT 3VRAYQ Top holdings2017-09-30 1.548862 2.AIMT 3.VRAYQ 4.ESPR 5.TRXCEUR 6.ADMA 7.29363K 8.171757 9.AGRXUSD 10.SYRSEUR
2017-06-30	16	$583.9M	55	15488622AIMT 3VRAYQ Top holdings2017-06-30 1.548862 2.AIMT 3.VRAYQ 4.ESPR 5.92529L 6.ADMA 7.PRTKEUR 8.SYRSEUR 9.171757 10.TRXCEUR
2017-03-31	17	$549.3M	29	1548862298933Q3AIMT Top holdings2017-03-31 1.548862 2.98933Q 3.AIMT 4.VRAYQ 5.92529L 6.ESPR 7.ADMA 8.89853L 9.TRXCEUR 10.PRTKEUR
2016-12-31	18	$430.1M	36	1548862298933Q3AIMT Top holdings2016-12-31 1.548862 2.98933Q 3.AIMT 4.92529L 5.VRAYQ 6.ESPR 7.ADMA 8.89853L 9.TRXCEUR 10.171757
2016-09-30	20	$485.4M	28	1548862298933Q3CTH Top holdings2016-09-30 1.548862 2.98933Q 3.CTH 4.AIMT 5.VRAYQ 6.92529L 7.15130J 8.ADMA 9.ESPR 10.89853L
2016-06-30	22	$423.5M	30	1548862298933Q3AIMT Top holdings2016-06-30 1.548862 2.98933Q 3.AIMT 4.VRAYQ 5.92529L 6.89853L 7.ADMA 8.15130J 9.AGRXUSD 10.CTH
2016-03-31	22	$499.4M	33	1548862298933Q3AIMT Top holdings2016-03-31 1.548862 2.98933Q 3.AIMT 4.TRXCEUR 5.VRAYQ 6.ADMA 7.89853L 8.ESPR 9.15130J 10.DERMEUR
2015-12-31	22	$579.8M	27	1548862215130J398933Q Top holdings2015-12-31 1.548862 2.15130J 3.98933Q 4.AIMT 5.ESPR 6.89853L 7.AGRXUSD 8.ADMA 9.DERMEUR 10.92529L
2015-09-30	22	$568.8M	54	198933Q2AIMT315130J Top holdings2015-09-30 1.98933Q 2.AIMT 3.15130J 4.548862 5.ESPR 6.ADMA 7.CMRXEUR 8.92529L 9.DERMEUR 10.89853L
2015-06-30	18	$671.6M	25	1ESPR298933Q315130J Top holdings2015-06-30 1.ESPR 2.98933Q 3.15130J 4.548862 5.CMRXEUR 6.89853L 7.92529L 8.ADMA 9.SRNE 10.AGRXUSD
2015-03-31	19	$764.2M	34	1ESPR215130J398933Q Top holdings2015-03-31 1.ESPR 2.15130J 3.98933Q 4.548862 5.92529L 6.89853L 7.CMRXEUR 8.ADMA 9.CTLTEUR 10.AGRXUSD
2014-12-31	19	$659.6M	51	1ESPR215130J398933Q Top holdings2014-12-31 1.ESPR 2.15130J 3.98933Q 4.CMRXEUR 5.CTLTEUR 6.89853L 7.92529L 8.548862 9.ADMA 10.PRTKEUR
2014-09-30	18	$515.7M	59	198933Q2ESPR389853L Top holdings2014-09-30 1.98933Q 2.ESPR 3.89853L 4.548862 5.CTLTEUR 6.CMRXEUR 7.92529L 8.TRXCEUR 9.15130J 10.26658A
2014-06-30	16	$346.0M	100	192529L2TRXCEUR398933Q Top holdings2014-06-30 1.92529L 2.TRXCEUR 3.98933Q 4.15130J 5.26658A 6.CMRXEUR 7.ESPR 8.AGRXUSD 9.71426V 10.SRNE
2014-03-31	5	$143.9M	41	174876Y226658A3CMRXEUR Top holdings2014-03-31 1.74876Y 2.26658A 3.CMRXEUR 4.MEIPUSD 5.SRNE
2013-12-31	6	$163.6M	0	174876Y226658A3CMRXEUR Top holdings2013-12-31 1.74876Y 2.26658A 3.CMRXEUR 4.ICPTUSD 5.57232I 6.SRNE

Holding changes this quarter

Position changes disclosed by Aisling Capital LLC for the quarter ending 2019-09-30, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	ADMA	Adma Biologics INC	+12.3%	—	Unchanged
2	✓	Cidara Therapeutics INC Com New	+1.1%	-12.69%	Trim
3	TRXCEUR	Transenterix INC	-2.1%	—	Unchanged
4	AIMT	Aimmune Therapeutics INC	-11.3%	-37.69%	Trim
5	VRAYQ	Viewray INC	—	NEW	New buy

Filing History

Period	Filed	Type	EDGAR
2019-09-30	2019-11-13	13F-HR	View on EDGAR
2019-06-30	2019-08-08	13F-HR	View on EDGAR
2019-03-31	2019-05-07	13F-HR	View on EDGAR
2018-12-31	2019-02-11	13F-HR	View on EDGAR
2018-09-30	2018-11-05	13F-HR	View on EDGAR
2018-06-30	2018-08-13	13F-HR	View on EDGAR
2018-03-31	2018-05-14	13F-HR	View on EDGAR
2017-12-31	2018-02-07	13F-HR	View on EDGAR
2017-09-30	2017-11-09	13F-HR	View on EDGAR
2017-06-30	2017-08-14	13F-HR	View on EDGAR
2017-03-31	2017-05-10	13F-HR	View on EDGAR
2016-12-31	2017-02-13	13F-HR	View on EDGAR
2016-09-30	2016-11-10	13F-HR	View on EDGAR
2016-06-30	2016-08-12	13F-HR	View on EDGAR
2016-03-31	2016-05-13	13F-HR	View on EDGAR
2015-12-31	2016-02-10	13F-HR	View on EDGAR
2015-09-30	2015-11-13	13F-HR	View on EDGAR
2015-06-30	2015-08-14	13F-HR	View on EDGAR
2015-03-31	2015-05-11	13F-HR	View on EDGAR
2014-12-31	2015-02-13	13F-HR	View on EDGAR
2014-09-30	2014-11-17	Amendment	View on EDGAR
2014-09-30	2014-11-13	13F-HR	View on EDGAR
2014-06-30	2014-09-12	Amendment	View on EDGAR
2014-06-30	2014-08-08	13F-HR	View on EDGAR
2014-03-31	2014-05-13	13F-HR	View on EDGAR
2013-12-31	2014-02-13	13F-HR	View on EDGAR